Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MK-8666 Tris is a partial GPCR agonist that is coordinated with the action of GPR40. MK-8666 has been investigated for treatment of type 2 diabetes mellitus.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,970.00 | |
50 mg | 8-10 weeks | $ 2,580.00 | |
100 mg | 8-10 weeks | $ 3,400.00 |
Description | MK-8666 Tris is a partial GPCR agonist that is coordinated with the action of GPR40. MK-8666 has been investigated for treatment of type 2 diabetes mellitus. |
Molecular Weight | 642.764 |
Formula | C33H42N2O9S |
CAS No. | 2056254-98-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MK-8666 Tris 2056254-98-7 AEVI001 monohydrate AEVI 001 monohydrate AEVI-001 monohydrate inhibitor inhibit